Sildenafil/Clomipramine Combo Boosts Outcomes in Premature Ejaculation

Efficacy and safety of behavioral therapy for premature ejaculation: protocol for a systematic review.

A Holistic Path to Sexual Confidence

Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation. Diagnostic and statistical manual of mental disorders: DSM-5. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine AdHoc Committee for the definition of premature ejaculation. Prevalence and correlates of premature ejaculation in a primary care setting: a preliminary cross-sectional study. Premature ejaculation and erectile dysfunction prevalence and attitudes in the Asia-Pacific region.

Fluoxetine (Prozac)

Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey. An update of the International Society of Sexual Medicine’s Guidelines for the diagnosis and treatment of premature ejaculation (PE). Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population.

Are off-label options a safe alternative to an FDA-approved medicine for premature ejaculation?

Characteristics of men who are bothered by rapid ejaculation: results from clinical intake surveys. Advances in understanding fildena super active 150mg and treating premature ejaculation. Frequency of etiological factors among patients with acquired premature ejaculation: prospective, observational, single-center study. Significance of penile hypersensitivity in premature ejaculation. Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M. Pelvic muscle floor rehabilitation as a therapeutic option in lifelong premature ejaculation: long-term outcomes.

Transcutaneous neuromuscular electrical stimulation may be beneficial in the treatment of premature ejaculation.

The Truth About FDA-Approved Treatments for PE

Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis. Association between lifelong premature ejaculation and polymorphism of tryptophan hydroxylase 2 gene in the Han population. The 5-HT2C receptor gene Cys23Ser polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation. Effects of paroxetine on intravaginal ejaculatory latency time in Egyptian patients with lifelong premature ejaculation as a function of serotonin transporter polymorphism. Study of the link between dopamine transporter gene polymorphisms and response to paroxetine and escitalopram in patients with lifelong premature ejaculation.

Ejaculation Problems: Too Fast, Too Slow or Not at All

Possible role of serum testosterone, gonadotropins and prolactin in patients with premature ejaculation. The relationship between premature ejaculation and hyperthyroidism. Sihotang RC, Alvonico T, Taher A, Birowo P, Rasyid N, Atmoko W. Premature ejaculation in patients with lower urinary tract symptoms: a systematic review. Chronic prostatitis in premature ejaculation: a cohort study in 153 men. Transcutaneous functional electrical stimulation — a novel therapy for premature ejaculation: results of a proof of concept study. A Novel, on-demand therapy for Lifelong Premature Ejaculation using a Miniature Trans-Perineal Electrical Stimulator, the vPatch® - as-treated analysis.

What is ejaculation?

Oral agents for the treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. Acceptance of and discontinuation rate from paroxetine treatment in patients with lifelong premature ejaculation. Real-life use of the eutectic mixture lidocaine/prilocaine spray in men with premature ejaculation. Abu El-Hamd M. Effectiveness and tolerability of lidocaine 5% spray in the treatment of lifelong premature ejaculation patients: a randomized single-blind placebo-controlled clinical trial. Peyronnet B, Amarenco G, Kerdraon J, Cornu JN, Gamé X. Transcutaneous posterior tibial nerve stimulation: ready for prime time.

• Dapoxetine is a fast-acting medication approved for PE.
• Combining medications with therapy enhances results.
• Some pills contain PDE5 inhibitors, like sildenafil, for better control.
• Side effects of pills may include dizziness or nausea.
• Always check for drug interactions before taking PE pills.

Giuliano F. Neurophysiology of erection and ejaculation.

• Topical anesthetic creams and sprays are alternative options.
• Lifestyle modifications, like reducing stress, are helpful adjuncts.
• Natural pills should be scrutinized for scientific validation.
• Contraceptive pills do not treat PE but are often confused with treatments.
• Medications may have different durations of action depending on formulation.

Puppo V, Puppo G.

How Safe are Premature Ejaculation Pills?

All patients underwent an 8-week Sphincter Control Training program. The sole distinction between the groups was the inclusion of the Myhixel © device. The primary metric was the “fold increase” in IELT. At the conclusion of the 8-week treatment, the geometric means of IELT demonstrated more favorable outcomes for the device group, albeit without statistical significance (P = 0.11) (an increase of 30 s versus 90 s from baseline in the exercise-only and device groups, respectively). Notably, in the device group, the fold increase in IELT was significantly higher compared to the exercise-only group, at 4.27 versus 2.09, respectively (P = 0.001) [53] (See Table 1 for comparison between the new technologies).

“Climax Control” Condoms

While there are treatments for PE that are actually, clinically proven, scientifically significant and FDA cleared (i.e behavioral therapies, topical anesthetics, and certain medications and medical devices), there are also numerous devices and products on the market that claim to treat or prevent PE but lack scientific evidence to support their efficacy (i.e Morari device- #how-it-works, Vaacum constriction devices, male vibrators). It’s crucial to approach any device claiming to treat PE with skepticism and caution unless there is robust scientific evidence supporting its efficacy and safety. Currently, the standards of care in PE treatment are mainly SSRIs and topical anesthetics. However, the available drug treatments for PE come with limited effectiveness, a range of adverse effects, and a high rate of discontinuation. A definitive cure for PE, or at least therapies allowing for spontaneity during intercourse, remain elusive.

The Psychological Component: Addressing the Mind

Encouragingly, data from studies utilizing newly developed technological techniques and medical devices in PE treatment show promise. Solutions that are drug-free, entail minimal adverse effects, and permit spontaneity during intercourse are on the horizon. However, additional clinical studies would be beneficial in confirming the effectiveness of these therapies, potentially establishing them as possible alternatives to pharmacological PE treatments. This is a review article with no original scientific data. Althof S. Comprehensive review of the anatomy and physiology of male ejaculation: premature ejaculation is not a disease.

Do Premature Ejaculation Pills Have Side Effects?

The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes. Mondaini N, Fusco F, Cai T, Benemei S, Mirone V, Bartoletti R. Dapoxetine treatment in patients with lifelong premature ejaculation: the reasons of a “Waterloo”. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. McMahon CG, Porst H. Transcutaneous electric nerve stimulation to treat patients with premature ejaculation: phase II clinical trial.

Aydos MM, Nas I, Önen E. The impact of transcutaneous posterior tibial nerve stimulation in patients with premature ejaculation. Efficacy of Sphincter Control Training and medical device in the treatment of premature ejaculation: a multicenter randomized controlled clinical trial.

• Some pills are available online but may lack quality control.
• Use of medication should be part of a comprehensive treatment plan.
• Understanding the cause of PE helps tailor the best pill choice.
• Long-term use requires medical guidance to avoid dependency.
• Combining pills with sexual therapy can boost confidence.

Tal Golan, Founder & CEO of Virility Medical, for his scientific contribution and Dr.

• Many pills aim to increase serotonin levels to delay ejaculation.
• Lifestyle factors like alcohol and smoking can worsen PE.
• Overuse of delay pills can cause dependence or reduced effectiveness.
• The placebo effect may improve perceived control with some pills.
• Consult a doctor for personalized treatment options.

Debby Mir for her scientific editing. Open access funding provided by Technion - Israel Institute of Technology. The authors declare no conflicts of interest related to this review manuscript.

Causes Of Premature Ejaculation

Only two patients reported complications, such as constipation (n = 1) and a sensation of heat in the leg (n = 1). Importantly, no reported adverse effects led to a change in therapy adherence. However, it is important to note that this study has significant limitations, including a very low number of participants, the absence of a control group, and a lack of randomization [51]. In a trial conducted in 2020, the effectiveness of TPTNS treatment was compared to sham therapy in a group of 60 men with PE. They underwent 30-min sessions of either TPTNS or sham therapy once a week.

Selective Serotonin Reuptake Inhibitors (SSRIs)

At the conclusion of the 12-week treatment period, the average IELT values increased from 40.4 s to 51.25 s for patients receiving TPTNS, while for those treated with sham therapy, the values went from 37.9 s to 42.5 s (P = 0.030) [52]. This study revealed an improvement in IELT scores in the Sham group, even though no electrical current was applied. This suggests that the contact of the TPTNS probe with the body may have induced a placebo effect. There were no statistically significant differences observed between patients treated with TPTNS or Sham in terms of the percentage change in IELT scores from pre-to-post-procedure (0.38 ± 0.47 vs. 0.23 ± 0.67, P = 0.415).

How Topical Anesthetics Work

However, it’s important to note that a major limitation of this study was the absence of randomization, potentially introducing bias in participant selection. The initial outcomes of TPTNS in treating PE appear conflicting, highlighting the need for randomized controlled studies involving large patient cohorts. In recent years, a new approach to treating PE has emerged, involving the use of a masturbation aid device in conjunction with behavioral techniques. In a multicenter randomized clinical trial utilizing a parallel group design to assess the effectiveness of the electronic masturbation device known as Myhixel © (MYHIXEL, Seville, Spain) in PE treatment, Rodriguez et al. assigned 52 patients to two treatment groups, with only 40 completing the study. Nevertheless, both authors have financial contracts with Virility Medical LTD, while two of the articles among the 53 reviewed in this work, were sponsored by Virility LTD.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.